Please Login to read the full article.
Clinica
Edwards' Q4 revenues disappoint, while profits hit by increased costs
06 February 2012
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- US reimbursement for TAVI is boost for Edwards but market may remain tough
- Will approval of Edwards' Sapien in lower-risk patients be delayed after panel meeting push-back?
- FDA approves trial expansion for Edwards' next-gen Sapien to include lower-risk patients
- Quarterly results round-up: LabCorp, Bard hit by legal costs; Edwards, Intuitive grow top and bottom lines
Other Informa News
EVENTS
